Dr. Rastinehad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 E 77th Street
5th Floor Black Hall
New York, NY 10075Phone+1 212-434-6580Fax+1 212-434-6690
Summary
- Northwell Health’s System Director for Prostate Cancer at the Cancer Institute
Vice Chair at the Smith Institute for Urology at Lenox Hill Hospital
Art Rastinehad, D.O. joined the faculty at Northwell Health in January 2020. He is the Northwell Health’s System Director for Prostate Cancer at the Cancer Institute and the Vice Chair of Urology at Lenox Hill Hospital. He trained at the National Cancer Institute as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship trained in Urologic Oncology and Interventional Radiology. He has expertise in a wide array of interventional radiological and surgical techniques, including image guided procedures, prostate artery embolization, laparoscopic and robotic surgery.
Dr. Rastinehad’s prostate cancer team has now incorporated state-of-the-art imaging to help visualize suspicious areas in the prostate for cancer. Dr. Rastinehad has also authored and implemented clinical trials of new techniques in the diagnosis and treatment of localized prostate cancer. In 2011 at Northwell Heath, he was the principal investigator for a Phase III clinical trial using MRI/Ultrasound fusion technology to improve prostate biopsy techniques. Using information from the prostate MRI, we can now target specific areas to better diagnose and quantify a patient’s prostate cancer. This was the first trial of this technology in the United States outside the National Institutes of Health.
This new clinical approach is helping to lay a foundation for the evaluation of a new technique, Focal Therapy, which only treats the diseased portion of the prostate. As of May 2016, Dr Rastinehad was the first in the world to perform a gold nano-particle directed ablation using an transperineal MR US Fusion guided focal therapy system. Dr Rastinehad and his team recently published the first series using this new technology in Proceedings of the National Academy of Science (PNAS).
Education & Training
- National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2009 - 2011
- Zucker School of Medicine at Hofstra/NorthwellResidency, Urology, 2004 - 2009
- Zucker School of Medicine at Hofstra/NorthwellFellowship, Vascular and Interventional Radiology, 2008 - 2008
- NYIT College Of Osteopathic MedicineClass of 2004
- Rochester Institute of TechnologyB.S., Biochemistry, 1993 - 1997
Certifications & Licensure
- NY State License 2007 - 2025
- MD State License 2010 - 2011
- American Board of Urology Urology
Awards, Honors, & Recognition
- The Arthur Smith Award for Innovation Endourological Society, 2021
- Young Urologists of the Year American Urological Association, 2019
- Best Paper Award Engineering and Urology Society, AUA (American Urological Association), 2017
- Join now to see all
Clinical Trials
- MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer Start of enrollment: 2012 May 01
- MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue Start of enrollment: 2016 Feb 01
- MR/TRUS Fusion Guided Prostate Biopsy Start of enrollment: 2018 May 11
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsPneumoperitoneum with carbon dioxide inhibits macrophage tumor necrosis factor-α secretion: Source of transitional-cell carcinoma port-site metastasis, with prophylact...Michael C. Ost, Keyur P. Patel, Ardeshir R. Rastinehad, Pui Yan Chu, Ann Anderson
Journal of Endourology. 2008-01-01 - 373 citationsMultiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic r...Baris Turkbey, Haresh Mani, Vijay Shah, Ardeshir R. Rastinehad, Marcelino Bernardo
The Journal of Urology. 2011-11-01 - 57 citationsAdvanced Diffusion-weighted Imaging Modeling for Prostate Cancer Characterization: Correlation with Quantitative Histopathologic Tumor Tissue Composition—A Hypothesis-...Stefanie J. Hectors, Sahar Semaan, Christopher Song, Sara Lewis, George K. Haines
Radiology. 2017-11-08
Journal Articles
- Estimated Costs Associated with Radiation Therapy for Positive Surgical Margins During Radical ProstatectomyAshutosh K Tewari, Ardeshir R Rastinehad, JAMA Network Open
- Implementation of Multiparametric Magnetic Resonance Imaging Technology for Evaluation of Patients with Suspicion for Prostate Cancer in the Clinical Practice SettingShah PH, Patel VR, Moreira DM, George AK, Alom M, Kozel Z, Joshi V, Ben-Levi E, Villani R, Yaskiv O, Kavoussi LR, Vira M, Olsson CO, Rastinehad AR, BJU Int, 1/16/2018
- Advanced Diffusion-weighted Imaging Modeling for Prostate Cancer Characterization: Correlation with Quantitative Histopathologic Tumor Tissue Composition-A Hypothesis-...Hectors SJ, Semaan S, Song C, Lewis S, Haines GK, Tewari A, Rastinehad AR, Taouli B, Radiology, 1/1/2018
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Mp26-10 Magnetic Resonance Imaging Guided Focal Laser Therapy Of Prostate Cancer: Follow Up Results From A Single Center Phase I Trial.Sherif Mehralivand, Arvin George, Anthony Hoang, Soroush Rais-Bahrami, Ardeshir Rastinehad, Vladimir Valera Romero, Jonathan Bloom, Samuel Gold, The Journal of Urology, AUA (American Urological Association), 1/1/2018
- Mp14-17 Role Of Magnetic Resonance Imaging In Predicting Adverse Pathology Post-Radical Prostatectomy.Alp Tuna Beksac, Ugo Falagario, Shivaram Cumarasamy, Akriti Gupta, Paige Xu, Sonya Prasad, Alberto Martini, Hari Thulasidass, The Journal of Urology, AUA (American Urological Association), 1/1/2018
- Mp14-12 Comparison Of Transperineal Systematic Biopsy Versus Transperineal Targeted Biopsy With Mr/Us Fusion Guidance And Electromagnetic (Em) Tracking For Suspicious ...Jared S. Winoker, Harry Anastos, Pratik A. Shukla, John P. Sfakianos, Cynthia J Knauer, Sara C. Lewis, Bachir A. Taouli, Ardeshir R. Rastinehad, The Journal of Urology, AUA (American Urological Association), 1/1/2018
- Join now to see all
Lectures
- Interventional Urology1/31/2018
- Focal Therapy and GSN directed ablation.1/20/2018
- MRI to Avoid of Biopsies1/1/2018
- Join now to see all
Other
- Prostate Cancer Screening: MR US Fusion Guided BiopsyRastinehad AR, Focus on Health, TV Channel 55 (10:30 am)
New York City - 1/11/2014 - The Prostate Fusion Biopsy ProgramRastinehad AR, Fox 5 News
http://www.foxnews.com/health/2013/04/09/new-prostate-cancer-technology-could-lead-to-more-targeted-therapies/
1/10/2013 - New Prostate Tumor Technology Called Equivalent Of GPSRastinehad AR, Newsday
1/2/2013 - Join now to see all
Authored Content
- Estimated Costs Associated with Radiation Therapy for Positive Surgical Margins During Radical ProstatectomyMarch 2020
- New Focal Therapy Advances in NanoMedicine for Prostate CancerAugust 2019
- Fusion Prostate Biopsy Outperforms 12-Core Systematic Prostate Biopsy in Patients with Prior Negative Systematic Biopsy: A Multi-Institutional AnalysisMay 2018
Press Mentions
- How ‘90210’ Star Brian Austin Green Learned to Manage His Ulcerative ColitisSeptember 14th, 2022
- Special Gold Shows Promise as Effective Treatment for Prostate CancerAugust 28th, 2019
- Quest for New Cancer Treatment Crosses MilestoneAugust 26th, 2019
- Join now to see all
Professional Memberships
- Member
External Links
- Art Rastinehadhttp://www.interventionalurology.com
- Fusion Biopsyhttp://www.fusion-biopsy.com
- Youtubehttps://www.youtube.com/channel/UCdktfeNDUCbomi3ww0gxCgg?view_as=subscriber
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: